[HTML][HTML] Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination

CA Morales-Paredes, JM Rodríguez-Díaz… - Science of the Total …, 2022‏ - Elsevier
During the COVID-19 pandemic, high consumption of antivirals, antibiotics, antiparasitics,
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …

From diagnosis to treatment: recent advances in patient-friendly biosensors and implantable devices

P Li, GH Lee, SY Kim, SY Kwon, HR Kim, S Park - ACS nano, 2021‏ - ACS Publications
Patient-friendly medical diagnostics and treatments have been receiving a great deal of
interest due to their rapid and cost-effective health care applications with minimized risk of …

Effect of hydroxychloroquine in hospitalized patients with Covid-19

RECOVERY Collaborative Group - New England Journal of …, 2020‏ - Mass Medical Soc
Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial

CP Skipper, KA Pastick, NW Engen… - Annals of internal …, 2020‏ - acpjournals.org
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

[HTML][HTML] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen… - International journal of …, 2020‏ - Elsevier
Abstract Significance The United States is in an acceleration phase of the COVID-19
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …

[HTML][HTML] Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey

JF Quispe-Cañari, E Fidel-Rosales, D Manrique… - Saudi pharmaceutical …, 2021‏ - Elsevier
Self-medication impacts both negatively and positively the health of people, which has
become evident during the COVID-19 pandemic. The study aimed to assess the prevalence …

Azithromycin in the treatment of COVID-19: a review

D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021‏ - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil …

RHM Furtado, O Berwanger, HA Fonseca, TD Corrêa… - The lancet, 2020‏ - thelancet.com
Background The efficacy and safety of azithromycin in the treatment of COVID-19 remain
uncertain. We assessed whether adding azithromycin to standard of care, which included …

Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation?

C Rhee, S Kanjilal, M Baker… - Clinical infectious …, 2021‏ - academic.oup.com
Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has major implications for public health and infection control practice in …

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

B Singh, H Ryan, T Kredo, M Chaplin… - Cochrane Database …, 2021‏ - cochranelibrary.com
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …